| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychiatry | 51 | 2024 | 1693 | 12.350 |
Why?
|
| Mental Disorders | 48 | 2024 | 6826 | 6.610 |
Why?
|
| Hospitals, General | 40 | 2024 | 798 | 6.040 |
Why?
|
| Referral and Consultation | 45 | 2024 | 3599 | 3.660 |
Why?
|
| Psychosomatic Medicine | 11 | 2019 | 71 | 3.250 |
Why?
|
| Delirium | 21 | 2024 | 1667 | 2.560 |
Why?
|
| Clozapine | 4 | 2024 | 504 | 1.660 |
Why?
|
| Inpatients | 18 | 2024 | 2545 | 1.630 |
Why?
|
| Education, Medical | 6 | 2021 | 1725 | 1.590 |
Why?
|
| Munchausen Syndrome | 8 | 2015 | 19 | 1.520 |
Why?
|
| Antipsychotic Agents | 16 | 2024 | 3067 | 1.510 |
Why?
|
| Catatonia | 3 | 2023 | 178 | 1.500 |
Why?
|
| Hallucinogens | 2 | 2024 | 197 | 1.450 |
Why?
|
| Self-Injurious Behavior | 6 | 2019 | 566 | 1.400 |
Why?
|
| Physician-Patient Relations | 17 | 2024 | 3239 | 1.340 |
Why?
|
| Bipolar Disorder | 13 | 2022 | 5091 | 1.320 |
Why?
|
| Psychotropic Drugs | 9 | 2016 | 888 | 1.250 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2020 | 625 | 1.160 |
Why?
|
| Cultural Competency | 3 | 2019 | 299 | 1.120 |
Why?
|
| Humans | 220 | 2024 | 760740 | 0.950 |
Why?
|
| Periodicals as Topic | 4 | 2019 | 1463 | 0.910 |
Why?
|
| Obsessive Behavior | 1 | 2024 | 51 | 0.910 |
Why?
|
| Conversion Disorder | 2 | 2019 | 202 | 0.890 |
Why?
|
| Peer Review, Research | 2 | 2019 | 339 | 0.890 |
Why?
|
| Diagnosis, Differential | 27 | 2024 | 12966 | 0.880 |
Why?
|
| Dyskinesias | 1 | 2024 | 79 | 0.860 |
Why?
|
| Emotional Intelligence | 2 | 2014 | 135 | 0.810 |
Why?
|
| Primary Health Care | 12 | 2024 | 4677 | 0.810 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2023 | 110 | 0.800 |
Why?
|
| Wernicke Encephalopathy | 1 | 2021 | 29 | 0.770 |
Why?
|
| Publishing | 3 | 2019 | 832 | 0.760 |
Why?
|
| Treatment Refusal | 6 | 2019 | 429 | 0.740 |
Why?
|
| Dystonia | 2 | 2024 | 370 | 0.740 |
Why?
|
| Writing | 3 | 2019 | 199 | 0.720 |
Why?
|
| Valerian | 1 | 2020 | 4 | 0.720 |
Why?
|
| Guanfacine | 1 | 2020 | 51 | 0.720 |
Why?
|
| Substance-Related Disorders | 9 | 2024 | 4416 | 0.700 |
Why?
|
| Movement Disorders | 1 | 2024 | 459 | 0.690 |
Why?
|
| Teaching | 3 | 2019 | 1169 | 0.680 |
Why?
|
| Health Facility Environment | 1 | 2019 | 32 | 0.670 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 617 | 0.670 |
Why?
|
| Polypharmacy | 2 | 2020 | 306 | 0.660 |
Why?
|
| Tourette Syndrome | 2 | 2021 | 395 | 0.650 |
Why?
|
| Negotiating | 2 | 2018 | 150 | 0.640 |
Why?
|
| Lorazepam | 1 | 2020 | 155 | 0.640 |
Why?
|
| Psychophysiologic Disorders | 3 | 2019 | 222 | 0.630 |
Why?
|
| Child Abuse, Sexual | 1 | 2021 | 403 | 0.630 |
Why?
|
| Antidepressive Agents | 11 | 2018 | 2896 | 0.620 |
Why?
|
| Interdisciplinary Communication | 3 | 2009 | 928 | 0.620 |
Why?
|
| Hypnotics and Sedatives | 4 | 2020 | 1178 | 0.620 |
Why?
|
| Antimanic Agents | 3 | 2017 | 520 | 0.610 |
Why?
|
| Interprofessional Relations | 4 | 2013 | 991 | 0.610 |
Why?
|
| Depressive Disorder | 9 | 2016 | 3735 | 0.600 |
Why?
|
| Hospitals, Psychiatric | 2 | 2019 | 319 | 0.600 |
Why?
|
| Paresis | 1 | 2019 | 176 | 0.590 |
Why?
|
| Amnesia | 1 | 2020 | 256 | 0.590 |
Why?
|
| Amputation, Traumatic | 1 | 2019 | 135 | 0.590 |
Why?
|
| Comorbidity | 11 | 2024 | 10507 | 0.580 |
Why?
|
| Alcoholism | 3 | 2024 | 1972 | 0.580 |
Why?
|
| Students, Medical | 3 | 2023 | 1936 | 0.570 |
Why?
|
| Thyroid Gland | 1 | 2023 | 1170 | 0.560 |
Why?
|
| Schizophrenia | 7 | 2024 | 6929 | 0.550 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2024 | 1492 | 0.550 |
Why?
|
| Academies and Institutes | 2 | 2017 | 318 | 0.540 |
Why?
|
| Factitious Disorders | 2 | 2011 | 39 | 0.530 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 6 | 2021 | 3708 | 0.530 |
Why?
|
| Crying | 1 | 2016 | 37 | 0.530 |
Why?
|
| Research Report | 1 | 2019 | 367 | 0.530 |
Why?
|
| Hand Injuries | 1 | 2019 | 239 | 0.530 |
Why?
|
| Patient Care Team | 8 | 2019 | 2515 | 0.520 |
Why?
|
| Hyperparathyroidism | 1 | 2017 | 337 | 0.520 |
Why?
|
| Myoclonus | 1 | 2016 | 107 | 0.520 |
Why?
|
| Dexmedetomidine | 1 | 2020 | 317 | 0.520 |
Why?
|
| Benzodiazepines | 13 | 2020 | 1133 | 0.510 |
Why?
|
| Cellulitis | 2 | 2015 | 209 | 0.510 |
Why?
|
| Internship and Residency | 11 | 2018 | 5878 | 0.510 |
Why?
|
| Patients' Rooms | 1 | 2015 | 62 | 0.500 |
Why?
|
| Nursing Staff, Hospital | 1 | 2018 | 348 | 0.500 |
Why?
|
| Faculty, Medical | 2 | 2021 | 1204 | 0.490 |
Why?
|
| Health Communication | 1 | 2018 | 212 | 0.490 |
Why?
|
| Transdermal Patch | 1 | 2015 | 51 | 0.490 |
Why?
|
| Books | 1 | 2014 | 22 | 0.490 |
Why?
|
| Lithium Carbonate | 4 | 2013 | 179 | 0.480 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 130 | 0.480 |
Why?
|
| Professional-Patient Relations | 4 | 2012 | 724 | 0.480 |
Why?
|
| Malingering | 2 | 2015 | 75 | 0.480 |
Why?
|
| Rabies | 1 | 2015 | 54 | 0.480 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 601 | 0.470 |
Why?
|
| Congresses as Topic | 1 | 2019 | 802 | 0.470 |
Why?
|
| Pericarditis, Constrictive | 1 | 2014 | 46 | 0.470 |
Why?
|
| Analgesics | 3 | 2018 | 1067 | 0.460 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2016 | 219 | 0.460 |
Why?
|
| Leadership | 2 | 2014 | 1385 | 0.460 |
Why?
|
| Long QT Syndrome | 2 | 2018 | 466 | 0.460 |
Why?
|
| Anti-Anxiety Agents | 8 | 2008 | 397 | 0.460 |
Why?
|
| Intraoperative Awareness | 1 | 2013 | 8 | 0.450 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2024 | 1473 | 0.450 |
Why?
|
| Safety Management | 1 | 2019 | 760 | 0.450 |
Why?
|
| Defense Mechanisms | 1 | 2014 | 180 | 0.450 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2014 | 41 | 0.450 |
Why?
|
| Dysarthria | 1 | 2013 | 58 | 0.440 |
Why?
|
| Anger | 1 | 2016 | 406 | 0.440 |
Why?
|
| Anxiety Disorders | 7 | 2022 | 2724 | 0.440 |
Why?
|
| Delivery of Health Care | 5 | 2021 | 5334 | 0.440 |
Why?
|
| Television | 2 | 2014 | 407 | 0.430 |
Why?
|
| Hinduism | 1 | 2012 | 14 | 0.420 |
Why?
|
| Borderline Personality Disorder | 4 | 2011 | 768 | 0.420 |
Why?
|
| Consultants | 1 | 2013 | 56 | 0.420 |
Why?
|
| Drug Prescriptions | 2 | 2016 | 1669 | 0.420 |
Why?
|
| Physician-Nurse Relations | 1 | 2012 | 20 | 0.410 |
Why?
|
| Publications | 1 | 2015 | 194 | 0.410 |
Why?
|
| Verbal Behavior | 2 | 2012 | 335 | 0.410 |
Why?
|
| Checklist | 1 | 2019 | 827 | 0.410 |
Why?
|
| Cultural Diversity | 1 | 2016 | 369 | 0.410 |
Why?
|
| Behavior Therapy | 2 | 2016 | 877 | 0.400 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2238 | 0.390 |
Why?
|
| Codes of Ethics | 1 | 2012 | 61 | 0.390 |
Why?
|
| Dissent and Disputes | 1 | 2013 | 146 | 0.390 |
Why?
|
| Reflex, Abnormal | 1 | 2011 | 83 | 0.380 |
Why?
|
| Ataxia | 1 | 2013 | 306 | 0.380 |
Why?
|
| Postoperative Complications | 7 | 2014 | 15609 | 0.380 |
Why?
|
| Drug Labeling | 1 | 2013 | 248 | 0.380 |
Why?
|
| Confidentiality | 1 | 2015 | 608 | 0.370 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 544 | 0.370 |
Why?
|
| Fraud | 1 | 2011 | 66 | 0.350 |
Why?
|
| Cognition Disorders | 5 | 2013 | 3979 | 0.350 |
Why?
|
| Grief | 1 | 2012 | 254 | 0.350 |
Why?
|
| Smoking Cessation | 1 | 2022 | 2056 | 0.350 |
Why?
|
| Bibliometrics | 1 | 2014 | 352 | 0.350 |
Why?
|
| Aggression | 2 | 2016 | 750 | 0.350 |
Why?
|
| Phenytoin | 1 | 2010 | 190 | 0.340 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 802 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 7403 | 0.340 |
Why?
|
| Deafness | 1 | 2014 | 459 | 0.340 |
Why?
|
| Carbamazepine | 1 | 2010 | 224 | 0.340 |
Why?
|
| Psychotic Disorders | 3 | 2023 | 3220 | 0.340 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2013 | 301 | 0.340 |
Why?
|
| Multiple Sclerosis | 3 | 2021 | 3222 | 0.330 |
Why?
|
| Dementia | 4 | 2021 | 2686 | 0.330 |
Why?
|
| Attitude to Death | 1 | 2012 | 400 | 0.330 |
Why?
|
| Central Nervous System Stimulants | 3 | 2013 | 1177 | 0.330 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2630 | 0.330 |
Why?
|
| Social Behavior | 2 | 2015 | 1135 | 0.320 |
Why?
|
| Patient Participation | 1 | 2018 | 1443 | 0.320 |
Why?
|
| Minority Groups | 1 | 2016 | 1202 | 0.320 |
Why?
|
| Hospitalists | 1 | 2013 | 294 | 0.320 |
Why?
|
| Suicide | 3 | 2013 | 1601 | 0.310 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2019 | 4575 | 0.310 |
Why?
|
| Pirenzepine | 2 | 1999 | 116 | 0.310 |
Why?
|
| Bereavement | 1 | 2012 | 309 | 0.310 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2014 | 628 | 0.310 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2008 | 56 | 0.300 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 309 | 0.300 |
Why?
|
| Lyme Disease | 1 | 2014 | 631 | 0.300 |
Why?
|
| Middle Aged | 52 | 2024 | 220603 | 0.290 |
Why?
|
| Haloperidol | 4 | 1995 | 389 | 0.290 |
Why?
|
| Veterans | 1 | 2021 | 2649 | 0.290 |
Why?
|
| Mood Disorders | 3 | 2013 | 1127 | 0.290 |
Why?
|
| Peer Review | 1 | 2009 | 217 | 0.290 |
Why?
|
| Male | 73 | 2022 | 360402 | 0.280 |
Why?
|
| Physician's Role | 2 | 2013 | 917 | 0.280 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 3351 | 0.280 |
Why?
|
| Aphasia | 2 | 2018 | 192 | 0.280 |
Why?
|
| Depressive Disorder, Major | 6 | 2019 | 4764 | 0.280 |
Why?
|
| Depression | 11 | 2023 | 8132 | 0.280 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1189 | 0.270 |
Why?
|
| Attitude | 1 | 2012 | 772 | 0.270 |
Why?
|
| Neurologic Examination | 5 | 2020 | 915 | 0.270 |
Why?
|
| Amiodarone | 1 | 2008 | 217 | 0.270 |
Why?
|
| Adult | 59 | 2020 | 220995 | 0.270 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1378 | 0.270 |
Why?
|
| Memory Disorders | 1 | 2013 | 1197 | 0.270 |
Why?
|
| Patient Education as Topic | 2 | 2019 | 2315 | 0.270 |
Why?
|
| Anesthesia, General | 1 | 2013 | 1173 | 0.260 |
Why?
|
| Dyspnea | 1 | 2014 | 1347 | 0.260 |
Why?
|
| Language Disorders | 1 | 2007 | 140 | 0.260 |
Why?
|
| Clothing | 1 | 2006 | 96 | 0.260 |
Why?
|
| Self Care | 1 | 2011 | 796 | 0.260 |
Why?
|
| Speech Disorders | 1 | 2007 | 180 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7390 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2013 | 1551 | 0.260 |
Why?
|
| Female | 76 | 2022 | 392203 | 0.260 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 3805 | 0.250 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2006 | 165 | 0.250 |
Why?
|
| Hypertension | 4 | 2018 | 8532 | 0.250 |
Why?
|
| Mental Competency | 3 | 2013 | 176 | 0.250 |
Why?
|
| Morbidity | 1 | 2010 | 1750 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2474 | 0.240 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 1996 | 223 | 0.240 |
Why?
|
| Restraint, Physical | 2 | 2023 | 186 | 0.240 |
Why?
|
| Cardiovascular Agents | 2 | 2011 | 840 | 0.240 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 1877 | 0.230 |
Why?
|
| Mentors | 2 | 2021 | 661 | 0.230 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 521 | 0.230 |
Why?
|
| Interpersonal Relations | 1 | 2011 | 1438 | 0.230 |
Why?
|
| Internal Medicine | 1 | 2010 | 1051 | 0.220 |
Why?
|
| Teaching Rounds | 2 | 2019 | 276 | 0.210 |
Why?
|
| Chest Pain | 2 | 2015 | 1091 | 0.210 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2002 | 17 | 0.210 |
Why?
|
| Poisoning | 3 | 1990 | 252 | 0.210 |
Why?
|
| Anticonvulsants | 3 | 2010 | 1910 | 0.210 |
Why?
|
| Quinolones | 1 | 2006 | 378 | 0.210 |
Why?
|
| Anxiety | 7 | 2000 | 4573 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.210 |
Why?
|
| Testosterone | 1 | 2013 | 2472 | 0.200 |
Why?
|
| Drug Interactions | 5 | 2010 | 1415 | 0.200 |
Why?
|
| Hepatic Encephalopathy | 1 | 2003 | 143 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 1230 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.200 |
Why?
|
| Paranoid Disorders | 1 | 2022 | 61 | 0.200 |
Why?
|
| Sexual Behavior | 1 | 2012 | 2187 | 0.200 |
Why?
|
| Mortality | 1 | 2013 | 2899 | 0.200 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8603 | 0.200 |
Why?
|
| Hospitalization | 4 | 2018 | 10708 | 0.200 |
Why?
|
| Aged | 35 | 2024 | 169092 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2016 | 9310 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 4010 | 0.200 |
Why?
|
| Pain | 2 | 2024 | 5062 | 0.190 |
Why?
|
| Lithium Compounds | 1 | 2002 | 223 | 0.180 |
Why?
|
| Accidental Falls | 1 | 2009 | 1067 | 0.180 |
Why?
|
| Sepsis | 1 | 2015 | 2585 | 0.180 |
Why?
|
| Hyperkinesis | 1 | 2021 | 89 | 0.180 |
Why?
|
| Patients | 2 | 2006 | 906 | 0.180 |
Why?
|
| Terminal Care | 1 | 2012 | 1755 | 0.180 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2373 | 0.180 |
Why?
|
| Emergency Services, Psychiatric | 2 | 2009 | 66 | 0.170 |
Why?
|
| Child | 10 | 2024 | 80089 | 0.160 |
Why?
|
| Neuropsychiatry | 1 | 2019 | 76 | 0.160 |
Why?
|
| Anesthesiology | 1 | 2009 | 1122 | 0.160 |
Why?
|
| Insurance, Health | 1 | 2011 | 2495 | 0.160 |
Why?
|
| Blindness | 1 | 2002 | 585 | 0.160 |
Why?
|
| Piperazines | 2 | 2006 | 2521 | 0.150 |
Why?
|
| Priapism | 1 | 1998 | 28 | 0.150 |
Why?
|
| Nurse's Role | 1 | 2019 | 188 | 0.150 |
Why?
|
| Delusions | 1 | 2000 | 298 | 0.150 |
Why?
|
| Psychomotor Agitation | 1 | 2020 | 305 | 0.150 |
Why?
|
| Prescriptions | 1 | 2020 | 386 | 0.150 |
Why?
|
| Flatulence | 1 | 2017 | 19 | 0.150 |
Why?
|
| Liver Transplantation | 2 | 2014 | 2328 | 0.150 |
Why?
|
| Replantation | 1 | 2019 | 145 | 0.150 |
Why?
|
| Puerperal Disorders | 1 | 2000 | 300 | 0.140 |
Why?
|
| Lithium | 3 | 1986 | 596 | 0.140 |
Why?
|
| Trust | 1 | 2022 | 529 | 0.140 |
Why?
|
| Death | 1 | 2022 | 674 | 0.140 |
Why?
|
| Sclerosis | 1 | 2017 | 210 | 0.140 |
Why?
|
| Patient Simulation | 1 | 2019 | 298 | 0.140 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2018 | 84 | 0.140 |
Why?
|
| Hospitals | 1 | 2010 | 3879 | 0.140 |
Why?
|
| Middle East | 1 | 2017 | 231 | 0.140 |
Why?
|
| Meprobamate | 1 | 1996 | 4 | 0.140 |
Why?
|
| Culture | 1 | 2000 | 623 | 0.130 |
Why?
|
| Disease Management | 2 | 2017 | 2506 | 0.130 |
Why?
|
| Sick Role | 3 | 2009 | 229 | 0.130 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 1996 | 35 | 0.130 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 618 | 0.130 |
Why?
|
| Psychotherapy | 3 | 2019 | 1648 | 0.130 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1999 | 253 | 0.130 |
Why?
|
| Somatoform Disorders | 3 | 2013 | 423 | 0.130 |
Why?
|
| Risk Management | 1 | 2019 | 557 | 0.130 |
Why?
|
| 1-Naphthylamine | 1 | 1995 | 49 | 0.130 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 328 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2016 | 23974 | 0.130 |
Why?
|
| Curriculum | 4 | 2021 | 3739 | 0.130 |
Why?
|
| Hematocrit | 2 | 2011 | 623 | 0.130 |
Why?
|
| Vestibular Diseases | 1 | 1998 | 231 | 0.130 |
Why?
|
| Dizziness | 1 | 1998 | 259 | 0.120 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2015 | 12 | 0.120 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 530 | 0.120 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2019 | 294 | 0.120 |
Why?
|
| Textbooks as Topic | 1 | 2014 | 19 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2020 | 858 | 0.120 |
Why?
|
| Music | 1 | 2018 | 245 | 0.120 |
Why?
|
| Burns | 2 | 2006 | 1875 | 0.120 |
Why?
|
| United States | 11 | 2018 | 72292 | 0.120 |
Why?
|
| Epilepsy | 1 | 2010 | 3303 | 0.120 |
Why?
|
| Back Pain | 1 | 2019 | 545 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2018 | 245 | 0.120 |
Why?
|
| Organizational Objectives | 1 | 2017 | 426 | 0.120 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1995 | 74 | 0.120 |
Why?
|
| Fecal Incontinence | 1 | 2017 | 242 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2017 | 443 | 0.120 |
Why?
|
| Panic Disorder | 1 | 1998 | 613 | 0.120 |
Why?
|
| Torsades de Pointes | 1 | 1995 | 78 | 0.120 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2015 | 39 | 0.120 |
Why?
|
| Pilot Projects | 5 | 2016 | 8619 | 0.120 |
Why?
|
| Social Isolation | 1 | 2017 | 365 | 0.120 |
Why?
|
| Cross-Cultural Comparison | 2 | 2012 | 634 | 0.120 |
Why?
|
| Propofol | 1 | 2020 | 602 | 0.120 |
Why?
|
| Decision Making | 3 | 2022 | 3919 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2024 | 1226 | 0.120 |
Why?
|
| Embolism, Air | 1 | 2014 | 109 | 0.110 |
Why?
|
| Emergency Service, Hospital | 3 | 2023 | 7873 | 0.110 |
Why?
|
| Group Processes | 1 | 2015 | 228 | 0.110 |
Why?
|
| Hand | 1 | 2019 | 902 | 0.110 |
Why?
|
| Headache | 2 | 2019 | 1255 | 0.110 |
Why?
|
| Bronchiectasis | 1 | 2015 | 139 | 0.110 |
Why?
|
| Play and Playthings | 1 | 1993 | 85 | 0.110 |
Why?
|
| Methylphenidate | 2 | 2010 | 488 | 0.110 |
Why?
|
| Endemic Diseases | 1 | 2014 | 191 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 2110 | 0.110 |
Why?
|
| Cooperative Behavior | 3 | 2009 | 1505 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2015 | 712 | 0.100 |
Why?
|
| Uganda | 1 | 2017 | 1332 | 0.100 |
Why?
|
| Disease Progression | 2 | 2023 | 13495 | 0.100 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 732 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 1999 | 1315 | 0.100 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2014 | 156 | 0.100 |
Why?
|
| Risk Factors | 18 | 2016 | 74128 | 0.100 |
Why?
|
| Informed Consent | 3 | 2013 | 1007 | 0.100 |
Why?
|
| Pericardial Effusion | 1 | 2014 | 247 | 0.100 |
Why?
|
| Ethics, Institutional | 1 | 2012 | 38 | 0.100 |
Why?
|
| Tranquilizing Agents | 1 | 2012 | 58 | 0.100 |
Why?
|
| Negativism | 1 | 2011 | 23 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2008 | 15498 | 0.100 |
Why?
|
| Electrocardiography | 6 | 2018 | 6346 | 0.100 |
Why?
|
| Stroke | 4 | 2018 | 9715 | 0.100 |
Why?
|
| Bupropion | 1 | 1993 | 304 | 0.100 |
Why?
|
| Insurance Claim Review | 1 | 2016 | 741 | 0.100 |
Why?
|
| Coronary Care Units | 3 | 1987 | 235 | 0.100 |
Why?
|
| Perception | 1 | 2018 | 1199 | 0.100 |
Why?
|
| Signal Detection, Psychological | 1 | 2011 | 84 | 0.090 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2012 | 99 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 4028 | 0.090 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 1985 | 390 | 0.090 |
Why?
|
| Affective Symptoms | 2 | 2012 | 417 | 0.090 |
Why?
|
| Inservice Training | 2 | 2012 | 375 | 0.090 |
Why?
|
| Pleural Effusion | 1 | 2014 | 341 | 0.090 |
Why?
|
| Social Stigma | 1 | 2017 | 769 | 0.090 |
Why?
|
| Massachusetts | 6 | 2016 | 8835 | 0.090 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 3882 | 0.090 |
Why?
|
| Personality Disorders | 2 | 1986 | 723 | 0.090 |
Why?
|
| Commitment of Mentally Ill | 1 | 1991 | 94 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2017 | 1178 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8652 | 0.090 |
Why?
|
| Psycholinguistics | 1 | 2010 | 79 | 0.090 |
Why?
|
| Self-Assessment | 1 | 1993 | 399 | 0.090 |
Why?
|
| Antihypertensive Agents | 3 | 2011 | 2018 | 0.090 |
Why?
|
| Vitamin D | 1 | 2024 | 3301 | 0.090 |
Why?
|
| Psychological Theory | 1 | 2011 | 175 | 0.090 |
Why?
|
| Thioridazine | 1 | 1990 | 33 | 0.090 |
Why?
|
| Data Collection | 1 | 2019 | 3316 | 0.090 |
Why?
|
| Societies, Medical | 2 | 2019 | 3901 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2192 | 0.090 |
Why?
|
| Professional Staff Committees | 1 | 2009 | 37 | 0.090 |
Why?
|
| Acetaminophen | 3 | 2003 | 555 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2007 | 1241 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2008 | 2152 | 0.080 |
Why?
|
| Desipramine | 1 | 1990 | 182 | 0.080 |
Why?
|
| Tachycardia | 3 | 1990 | 597 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1835 | 0.080 |
Why?
|
| Homosexuality, Male | 1 | 2017 | 1333 | 0.080 |
Why?
|
| Time Factors | 6 | 2019 | 39908 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1157 | 0.080 |
Why?
|
| Mass Media | 1 | 2012 | 302 | 0.080 |
Why?
|
| Lung Diseases | 1 | 1999 | 1909 | 0.080 |
Why?
|
| Tranylcypromine | 1 | 1988 | 30 | 0.080 |
Why?
|
| Counseling | 1 | 2016 | 1538 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2009 | 222 | 0.080 |
Why?
|
| Spouses | 1 | 2011 | 283 | 0.080 |
Why?
|
| Awareness | 1 | 1993 | 649 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2008 | 48 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1990 | 432 | 0.080 |
Why?
|
| Nortriptyline | 1 | 1988 | 79 | 0.080 |
Why?
|
| Professional-Family Relations | 1 | 2012 | 495 | 0.080 |
Why?
|
| Organizational Culture | 1 | 2012 | 509 | 0.070 |
Why?
|
| Homicide | 1 | 1991 | 294 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1795 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2010 | 6016 | 0.070 |
Why?
|
| Stress, Psychological | 5 | 2017 | 4488 | 0.070 |
Why?
|
| Rage | 2 | 2003 | 30 | 0.070 |
Why?
|
| Career Mobility | 1 | 2009 | 259 | 0.070 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 978 | 0.070 |
Why?
|
| Morphine | 1 | 2011 | 655 | 0.070 |
Why?
|
| Patient Care | 1 | 2013 | 621 | 0.070 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 982 | 0.070 |
Why?
|
| Psychotherapy, Brief | 1 | 1987 | 118 | 0.070 |
Why?
|
| Palliative Care | 1 | 2022 | 3593 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9171 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 1509 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 1457 | 0.070 |
Why?
|
| Cholinergic Antagonists | 1 | 2007 | 167 | 0.070 |
Why?
|
| Dibenzothiazepines | 1 | 2006 | 102 | 0.070 |
Why?
|
| Professional Competence | 1 | 2009 | 431 | 0.070 |
Why?
|
| Somnambulism | 1 | 1986 | 13 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 2164 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 15702 | 0.070 |
Why?
|
| Learning | 1 | 2015 | 1740 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 59191 | 0.060 |
Why?
|
| Affect | 1 | 2013 | 1486 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 7050 | 0.060 |
Why?
|
| Confusion | 1 | 2008 | 278 | 0.060 |
Why?
|
| Myocardial Infarction | 5 | 2001 | 11458 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2009 | 1045 | 0.060 |
Why?
|
| Age Factors | 3 | 2012 | 18381 | 0.060 |
Why?
|
| Cost of Illness | 2 | 2016 | 1937 | 0.060 |
Why?
|
| Program Development | 1 | 2011 | 1293 | 0.060 |
Why?
|
| Documentation | 1 | 2011 | 896 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2011 | 1418 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2006 | 186 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2009 | 486 | 0.060 |
Why?
|
| Wounds and Injuries | 2 | 2009 | 2492 | 0.060 |
Why?
|
| Atenolol | 1 | 2005 | 99 | 0.060 |
Why?
|
| Trazodone | 1 | 1984 | 68 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1202 | 0.060 |
Why?
|
| Personality | 1 | 1987 | 553 | 0.060 |
Why?
|
| Physostigmine | 1 | 1983 | 50 | 0.060 |
Why?
|
| Agoraphobia | 2 | 1998 | 177 | 0.060 |
Why?
|
| Parasympatholytics | 1 | 1983 | 88 | 0.060 |
Why?
|
| Benztropine | 2 | 1983 | 17 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 10754 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1447 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2004 | 103 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 983 | 0.050 |
Why?
|
| Nurse-Patient Relations | 1 | 2003 | 99 | 0.050 |
Why?
|
| Digoxin | 1 | 1984 | 246 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1990 | 1017 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2011 | 2486 | 0.050 |
Why?
|
| Tegmentum Mesencephali | 1 | 2002 | 59 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1470 | 0.050 |
Why?
|
| Catecholamines | 1 | 2003 | 387 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2010 | 1400 | 0.050 |
Why?
|
| Intensive Care Units | 3 | 1993 | 3743 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2011 | 2242 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2160 | 0.050 |
Why?
|
| Steroids | 1 | 2007 | 928 | 0.050 |
Why?
|
| Prognosis | 5 | 2016 | 29601 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 1320 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2011 | 58919 | 0.050 |
Why?
|
| Security Measures | 1 | 1982 | 82 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2011 | 12333 | 0.050 |
Why?
|
| Personality Assessment | 1 | 2003 | 649 | 0.050 |
Why?
|
| Geniculate Bodies | 1 | 2002 | 158 | 0.050 |
Why?
|
| Electronic Health Records | 2 | 2016 | 4810 | 0.050 |
Why?
|
| Education | 2 | 1996 | 534 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1163 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 5838 | 0.050 |
Why?
|
| Hemoglobinometry | 1 | 2000 | 35 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2009 | 1116 | 0.050 |
Why?
|
| Disease | 1 | 1986 | 670 | 0.040 |
Why?
|
| Drug Therapy, Combination | 4 | 1998 | 6305 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 2002 | 324 | 0.040 |
Why?
|
| Emergencies | 2 | 1990 | 1217 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2003 | 421 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 1413 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2018 | 26065 | 0.040 |
Why?
|
| Erythrocyte Indices | 1 | 2000 | 144 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2010 | 1393 | 0.040 |
Why?
|
| Tropanes | 1 | 1979 | 48 | 0.040 |
Why?
|
| Heart Rate | 2 | 2010 | 4181 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2007 | 3245 | 0.040 |
Why?
|
| Heptanoic Acids | 1 | 2001 | 344 | 0.040 |
Why?
|
| Health Personnel | 1 | 1993 | 3333 | 0.040 |
Why?
|
| Recurrence | 4 | 2014 | 8426 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 3451 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2008 | 6240 | 0.040 |
Why?
|
| Suicide, Attempted | 2 | 1984 | 1402 | 0.040 |
Why?
|
| Patient Compliance | 2 | 2011 | 2688 | 0.040 |
Why?
|
| Health Services | 1 | 2003 | 751 | 0.040 |
Why?
|
| Family Practice | 2 | 1998 | 507 | 0.040 |
Why?
|
| Penile Erection | 1 | 1998 | 101 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8516 | 0.040 |
Why?
|
| Coronary Disease | 3 | 2000 | 5911 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 407 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20556 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2007 | 2073 | 0.040 |
Why?
|
| Incidence | 2 | 2011 | 21339 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13383 | 0.040 |
Why?
|
| Electroconvulsive Therapy | 3 | 2000 | 500 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2011 | 3269 | 0.030 |
Why?
|
| Advance Directives | 1 | 1999 | 249 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 2001 | 888 | 0.030 |
Why?
|
| Epilepsies, Partial | 1 | 2000 | 431 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 1999 | 270 | 0.030 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 1985 | 1073 | 0.030 |
Why?
|
| Brain | 6 | 2018 | 27100 | 0.030 |
Why?
|
| Staff Development | 1 | 2018 | 227 | 0.030 |
Why?
|
| Patient Admission | 2 | 1996 | 1365 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2003 | 834 | 0.030 |
Why?
|
| Hospital Records | 1 | 1996 | 93 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9277 | 0.030 |
Why?
|
| Mothers | 1 | 2006 | 2194 | 0.030 |
Why?
|
| Current Procedural Terminology | 1 | 2016 | 89 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4325 | 0.030 |
Why?
|
| New York | 1 | 1998 | 875 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 8473 | 0.030 |
Why?
|
| Heart | 1 | 1988 | 4403 | 0.030 |
Why?
|
| Pyrroles | 1 | 2001 | 1125 | 0.030 |
Why?
|
| Medical Audit | 1 | 1996 | 453 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1995 | 266 | 0.030 |
Why?
|
| Phobic Disorders | 2 | 1988 | 439 | 0.030 |
Why?
|
| Irritable Mood | 1 | 1995 | 194 | 0.030 |
Why?
|
| Sertraline | 1 | 1995 | 209 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 5031 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2011 | 54364 | 0.030 |
Why?
|
| Low Back Pain | 1 | 2002 | 982 | 0.030 |
Why?
|
| Social Facilitation | 1 | 1993 | 31 | 0.030 |
Why?
|
| Vertigo | 1 | 1995 | 202 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1998 | 829 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 967 | 0.030 |
Why?
|
| Patient Discharge | 2 | 1998 | 3442 | 0.030 |
Why?
|
| Eating | 1 | 2020 | 1535 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2010 | 4010 | 0.030 |
Why?
|
| Delayed-Action Preparations | 2 | 2010 | 962 | 0.030 |
Why?
|
| Social Support | 1 | 2003 | 2174 | 0.030 |
Why?
|
| Tinnitus | 1 | 1995 | 196 | 0.030 |
Why?
|
| Acute Disease | 1 | 2003 | 7236 | 0.030 |
Why?
|
| Gangliosidoses | 1 | 1992 | 5 | 0.030 |
Why?
|
| Physicians | 1 | 2010 | 4583 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 1331 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 1985 | 1923 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 160 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 463 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 1974 | 288 | 0.020 |
Why?
|
| Airway Obstruction | 2 | 1988 | 661 | 0.020 |
Why?
|
| Fluoxetine | 2 | 1992 | 733 | 0.020 |
Why?
|
| Career Choice | 1 | 2018 | 757 | 0.020 |
Why?
|
| Retrospective Studies | 7 | 2011 | 80583 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2015 | 549 | 0.020 |
Why?
|
| Third-Party Consent | 1 | 2011 | 66 | 0.020 |
Why?
|
| PubMed | 1 | 2012 | 129 | 0.020 |
Why?
|
| Gestational Age | 1 | 2000 | 3577 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 1376 | 0.020 |
Why?
|
| Panic | 2 | 1988 | 103 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 315 | 0.020 |
Why?
|
| Dangerous Behavior | 1 | 1991 | 65 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1419 | 0.020 |
Why?
|
| Alprazolam | 2 | 1988 | 103 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 2214 | 0.020 |
Why?
|
| Obstetrics | 1 | 1977 | 666 | 0.020 |
Why?
|
| Necrosis | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Proxy | 1 | 2011 | 151 | 0.020 |
Why?
|
| Adolescent | 7 | 2010 | 88247 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2022 | 1717 | 0.020 |
Why?
|
| Gait | 1 | 1995 | 811 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 286 | 0.020 |
Why?
|
| Algorithms | 2 | 2016 | 14024 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2011 | 282 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 500 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2010 | 138 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 3 | 1990 | 2234 | 0.020 |
Why?
|
| Psychology | 1 | 2011 | 356 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2002 | 39062 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36401 | 0.020 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1988 | 144 | 0.020 |
Why?
|
| Fatigue | 1 | 1995 | 1550 | 0.020 |
Why?
|
| Length of Stay | 2 | 2016 | 6418 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 436 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13635 | 0.020 |
Why?
|
| Electrodiagnosis | 1 | 1988 | 148 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2756 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1993 | 1436 | 0.020 |
Why?
|
| New England | 1 | 2010 | 1050 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 11670 | 0.020 |
Why?
|
| Consciousness Disorders | 1 | 2011 | 441 | 0.020 |
Why?
|
| Dehydration | 2 | 1986 | 216 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 1995 | 1261 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2278 | 0.020 |
Why?
|
| Masochism | 1 | 1986 | 4 | 0.020 |
Why?
|
| Caregivers | 1 | 1999 | 2241 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 1540 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1667 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1408 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Heart Diseases | 2 | 1988 | 2778 | 0.020 |
Why?
|
| Automatism | 1 | 1984 | 10 | 0.020 |
Why?
|
| Attention | 1 | 1995 | 2396 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6403 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 64572 | 0.010 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1985 | 81 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2851 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3410 | 0.010 |
Why?
|
| Diabetic Neuropathies | 1 | 1988 | 405 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 861 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1983 | 397 | 0.010 |
Why?
|
| Reinforcement Schedule | 1 | 2003 | 123 | 0.010 |
Why?
|
| Amitriptyline | 1 | 1983 | 112 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 1186 | 0.010 |
Why?
|
| Risk | 2 | 1986 | 9603 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1974 | 3095 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1985 | 685 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2003 | 260 | 0.010 |
Why?
|
| Internal-External Control | 1 | 2003 | 358 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6483 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2016 | 5074 | 0.010 |
Why?
|
| Neurology | 1 | 2009 | 784 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1995 | 3527 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1990 | 3796 | 0.010 |
Why?
|
| Ohio | 1 | 2000 | 322 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 3611 | 0.010 |
Why?
|
| Social Perception | 1 | 2003 | 431 | 0.010 |
Why?
|
| Communication | 1 | 1993 | 3851 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1979 | 61 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3837 | 0.010 |
Why?
|
| Relaxation Therapy | 1 | 2000 | 181 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36157 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14649 | 0.010 |
Why?
|
| Fear | 1 | 1986 | 1477 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 1986 | 1361 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13248 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2011 | 3801 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1986 | 2090 | 0.010 |
Why?
|
| Cineangiography | 1 | 1974 | 108 | 0.010 |
Why?
|
| Health Status | 1 | 2008 | 4076 | 0.010 |
Why?
|
| Vectorcardiography | 1 | 1974 | 48 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15829 | 0.010 |
Why?
|
| Family Health | 1 | 1999 | 1253 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1995 | 623 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 4919 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 783 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2009 | 4790 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1974 | 276 | 0.010 |
Why?
|
| Emotions | 1 | 1984 | 2741 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2632 | 0.010 |
Why?
|
| G(M2) Ganglioside | 1 | 1992 | 15 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 5425 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1992 | 44 | 0.010 |
Why?
|
| Myocardium | 1 | 1985 | 4725 | 0.010 |
Why?
|
| Half-Life | 1 | 1992 | 650 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1974 | 748 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1990 | 63 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1984 | 7805 | 0.010 |
Why?
|
| Lipids | 1 | 2001 | 3332 | 0.010 |
Why?
|
| Lymphoma | 1 | 1999 | 1899 | 0.010 |
Why?
|
| Salicylates | 1 | 1990 | 127 | 0.010 |
Why?
|
| Barbiturates | 1 | 1990 | 113 | 0.010 |
Why?
|
| Hallucinations | 1 | 1992 | 366 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1974 | 816 | 0.010 |
Why?
|
| Diazepam | 1 | 1990 | 215 | 0.000 |
Why?
|
| Alcoholic Intoxication | 1 | 1990 | 174 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2001 | 10072 | 0.000 |
Why?
|
| Heart Block | 1 | 1990 | 384 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1974 | 1302 | 0.000 |
Why?
|
| Quality Assurance, Health Care | 1 | 1998 | 2164 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12448 | 0.000 |
Why?
|
| Neoplasms | 2 | 1992 | 22131 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1988 | 639 | 0.000 |
Why?
|
| Electric Countershock | 1 | 1988 | 532 | 0.000 |
Why?
|
| Ureteral Calculi | 1 | 1986 | 114 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1988 | 12143 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1985 | 414 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1979 | 7995 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1992 | 2768 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1985 | 1687 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26183 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1988 | 2025 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1995 | 6635 | 0.000 |
Why?
|
| Body Weight | 1 | 1986 | 4615 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1988 | 6390 | 0.000 |
Why?
|
| Animals | 1 | 1984 | 168202 | 0.000 |
Why?
|